Publicaciones en colaboración con investigadores/as de University Hospital of Zurich (11)

2020

  1. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

    Journal of cardiovascular pharmacology, Vol. 76, Núm. 1, pp. 4-22

  2. Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

    Cardiac Failure Review, Vol. 6

2015

  1. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey

    Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9

2013

  1. Gender-related differences in patients with acute heart failure: Management and predictors of in-hospital mortality

    International Journal of Cardiology, Vol. 168, Núm. 1, pp. 185-189

2012

  1. Acute heart failure in patients with diabetes mellitus: Clinical characteristics and predictors of in-hospital mortality

    International Journal of Cardiology, Vol. 157, Núm. 1, pp. 108-113

2011

  1. Clinical characteristics and predictors of in-hospital mortality in acute heart failure with preserved left ventricular ejection fraction

    American Journal of Cardiology, Vol. 107, Núm. 1, pp. 79-84

  2. Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)

    Intensive Care Medicine, Vol. 37, Núm. 4, pp. 619-626

  3. Short-term survival by treatment among patients hospitalized with acute heart failure: The global ALARM-HF registry using propensity scoring methods

    Intensive Care Medicine, Vol. 37, Núm. 2, pp. 290-301

2010

  1. Acute pulmonary oedema: Clinical characteristics, prognostic factors, and in-hospital management

    European Journal of Heart Failure, Vol. 12, Núm. 11, pp. 1193-1202

2008

  1. Levosimendan in the treatment of AHF: Lessons from surveys and clinical trials

    European Journal of Heart Failure, Supplement, Vol. 7, Núm. SUPPL. 2, pp. 228-233

  2. Levosimendan: A decade of experience in Europe built on years of evidence

    European Journal of Heart Failure, Supplement, Vol. 7, Núm. SUPPL. 2, pp. 234-243